|
|
|
Home > Business > Reuters > Report
Ranbaxy gets FDA nod for Fluconazole tablets
May 06, 2003 12:50 IST
Ranbaxy Laboratories has received tentative approval form the Food & Drug Administration USA for manufacturing and marketing Fluconazole tablets, according to a release issued by the company to the Bombay Stock Exchange on Tuesday. Fluconazole tablets are therapeutically equivalent to the reference listed drug Diflucan tablets of Pfizer Central Research, the release said. Diflucan is indicated for the treatment of vaginal candidiasis, oropharyngeal and esophageal candidiasis and cryptococcal meningitis, the release added.
© Copyright 2003 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
|
|
|
| Article Tools | | |
| Related Stories | | |
| People Who Read This Also Read | | |
|